GENE THERAPY: USING GENES AS MEDICINE
Gene therapy is the next generation of medicine targeting the underlying cause of a genetic disease. It has the potential to offer patients a transformational clinical benefit and dramatically improve quality of life.
GENETICS: KEY TERMS
What is a Gene?
A gene is the basic physical and functional unit of heredity, and is made up of DNA. The Human Genome Project estimated that humans have between 20,000 and 25,000 genes. Though small, our genes are a blueprint for how each cell in the body functions, made up of 30 million codes of DNA.
What is a Genetic Disease?
A genetic disease is caused by an alteration in an individual’s DNA, oftentimes inherited or, in rare cases, occurring spontaneously. Genes play an essential role in determining the function of each cell in the body, made up of 30 million codes of DNA. If even one of these codes is damaged, a gene alteration may occur causing a genetic disease, some of which can be debilitating and life-threatening.
What is Gene Therapy?
Gene therapy is a new generation of medicine where a functioning gene is delivered to a targeted tissue in the body to produce a missing or nonfunctioning protein. By using genes as medicine, the underlying cause of a disease can be targeted at the cellular level, potentially with just one treatment.
What is in vivo Gene Therapy? What is ex vivo Gene Therapy?
For in vivo, the functioning gene is transferred to the cell inside the body via an infusion and is used as a blueprint to produce the missing or nonfunctioning protein. For ex vivo, patient’s cells are removed and exposed to the desired gene outside of the body, then re-infused to add the functioning gene back in the body.
What is Gene Editing?
Gene editing is a precise change of a patient’s DNA using site-specific, targeted nucleases (eg, CRISPR, Zinc Finger). This approach either permanently removes or modifies a gene, or adds a functioning gene within the patient’s body.
Are There Other Genetic Approaches?
Another approach uses RNAi technology to change the expression of a gene by targeting product of DNA transcription (RNA). This approach more or less “silences” the dysfunctional gene attributed to the genetic disease.